167 related articles for article (PubMed ID: 36794502)
41. Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study.
Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K
Int J Hematol; 2023 Feb; 117(2):206-215. PubMed ID: 36308678
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis and management of adult T-cell leukemia/lymphoma.
Ishitsuka K
Semin Hematol; 2021 Apr; 58(2):114-122. PubMed ID: 33906721
[TBL] [Abstract][Full Text] [Related]
43. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
[TBL] [Abstract][Full Text] [Related]
44. Possibility of a risk-adapted treatment strategy for untreated aggressive adult T-cell leukaemia-lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG9801.
Toyoda K; Tsukasaki K; Machida R; Kadota T; Fukushima T; Ishitsuka K; Maruyama D; Nagai H
Br J Haematol; 2019 Aug; 186(3):440-447. PubMed ID: 31099033
[TBL] [Abstract][Full Text] [Related]
45. Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience.
Fukushima T; Taguchi J; Moriuchi Y; Yoshida S; Itonaga H; Ando K; Sawayama Y; Imaizumi Y; Imanishi D; Hata T; Miyazaki Y
Int J Hematol; 2011 Oct; 94(4):390-394. PubMed ID: 21960057
[TBL] [Abstract][Full Text] [Related]
46. [Impact of pretransplant anti-CCR4 antibody administration on clinical outcomes in allogeneic hematopoietic stem cell transplantation].
Fuji S
Rinsho Ketsueki; 2019; 60(8):968-972. PubMed ID: 31484897
[TBL] [Abstract][Full Text] [Related]
47. A case series of adult T-cell leukemia-lymphoma, associated with human T-cell leukemia virus type-1, at a single center in a non-viral-endemic metropolitan area.
Akuzawa Y; Tsukasaki K; Saeki T; Okamura D; Ishikawa M; Maeda T; Kohri M; Takahashi N; Matsuda A; Kawai N; Asou N
J Clin Exp Hematop; 2019; 59(3):108-111. PubMed ID: 31564712
[TBL] [Abstract][Full Text] [Related]
48. [Role of anti-CCR4 antibody in the treatment of transplant-eligible patients with aggressive adult T-cell leukemia/lymphoma].
Fuji S
Rinsho Ketsueki; 2018; 59(4):426-431. PubMed ID: 29743403
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic options for adult T-cell leukemia/lymphoma.
Marçais A; Suarez F; Sibon D; Frenzel L; Hermine O; Bazarbachi A
Curr Oncol Rep; 2013 Oct; 15(5):457-64. PubMed ID: 23943384
[TBL] [Abstract][Full Text] [Related]
50. Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.
Fuji S; Fujiwara H; Nakano N; Wake A; Inoue Y; Fukuda T; Hidaka M; Moriuchi Y; Miyamoto T; Uike N; Taguchi J; Eto T; Tomoyose T; Kondo T; Yamanoha A; Ichinohe T; Atsuta Y; Utsunomiya A;
Bone Marrow Transplant; 2016 Feb; 51(2):205-11. PubMed ID: 26524263
[TBL] [Abstract][Full Text] [Related]
51. Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia.
Hishizawa M; Imada K; Sakai T; Nishikori M; Arima N; Tsudo M; Ishikawa T; Uchiyama T
Int J Hematol; 2006 May; 83(4):351-5. PubMed ID: 16757438
[TBL] [Abstract][Full Text] [Related]
52. [Clinical analysis on adult acute T-lymphoblastic leukemia].
Zhang Q; Zhou CL; Fu MW; Wang JY; Lin D; Liu BC; Li W; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):478-82. PubMed ID: 22541122
[TBL] [Abstract][Full Text] [Related]
53. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
[TBL] [Abstract][Full Text] [Related]
54. Treatment and survival among 1594 patients with ATL.
Katsuya H; Ishitsuka K; Utsunomiya A; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Amano M; Hino R; Shimokawa M; Kawai K; Suzumiya J; Tamura K;
Blood; 2015 Dec; 126(24):2570-7. PubMed ID: 26361794
[TBL] [Abstract][Full Text] [Related]
55. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL].
Tanaka Y; Kanda Y
Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144
[TBL] [Abstract][Full Text] [Related]
56. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.
Ishida T; Hishizawa M; Kato K; Tanosaki R; Fukuda T; Taniguchi S; Eto T; Takatsuka Y; Miyazaki Y; Moriuchi Y; Hidaka M; Akashi K; Uike N; Sakamaki H; Morishima Y; Kato K; Suzuki R; Nishiyama T; Utsunomiya A
Blood; 2012 Aug; 120(8):1734-41. PubMed ID: 22689862
[TBL] [Abstract][Full Text] [Related]
57. [Adult T cell leukemia/lymphoma (ATL)].
Tanosaki R
Nihon Rinsho; 2003 Sep; 61(9):1592-5. PubMed ID: 14515729
[TBL] [Abstract][Full Text] [Related]
58. Transplant-related complications are impediments to the success of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia patients in non-complete remission.
Tomori S; Morishima S; Nishi Y; Nakachi S; Tamaki K; Morichika K; Tedokon I; Shimabukuro N; Hanashiro T; Kitamura S; Uchibori S; Miyagi R; Miyagi T; Karimata K; Ohama M; Yamanoha A; Tomoyose T; Karube K; Fukushima T; Masuzaki H
Bone Marrow Transplant; 2020 Jan; 55(1):233-241. PubMed ID: 31534195
[TBL] [Abstract][Full Text] [Related]
59. Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation.
Hu M; Wang H; Wang L; Yang M; Lou Y; Jin J
Medicine (Baltimore); 2018 Jul; 97(28):e11374. PubMed ID: 29995776
[TBL] [Abstract][Full Text] [Related]
60. Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission.
Zhang Y; Bai L; Cheng Y; Lu A; Wang Y; Wu J; Zhang X; Zuo Y; Xu L; Jia Y; Huang X; Zhang L
Chin Med J (Engl); 2022 Apr; 135(8):940-949. PubMed ID: 35730372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
